| Date Filed | Type | Description |
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/02/2023 |
8-K
| Quarterly results |
| 05/25/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/17/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 6.7% stake in SpringWorks Therapeutics, Inc. |
| 05/03/2023 |
8-K
| Quarterly results |
| 05/03/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/20/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/10/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 02/28/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 02/28/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/28/2023 |
8-K
| Quarterly results |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 4.2% stake in SpringWorks Therapeutics, Inc. |
| 02/10/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 15% stake in SPRINGWORKS THERAPEUTICS INC |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 6.9% stake in SpringWorks Therapeutics Inc. |
| 02/07/2023 |
SC 13G
| BlackRock Inc. reports a 5.3% stake in SpringWorks Therapeutics, Inc. |
| 01/05/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/03/2022 |
8-K
| Quarterly results |
| 11/03/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 09/26/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 09/19/2022 |
SC 13G
| Boxer Capital, LLC reports a 5.7% stake in SpringWorks Therapeutics, Inc. |
| 09/19/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 5.5% stake in Springworks Therapeutics, Inc. |
| 09/16/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/14/2022 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 9.3% stake in SpringWorks Therapeutics, Inc. |
| 09/13/2022 |
SC 13D/A
| BC SW, LP reports a 8% stake in SpringWorks Therapeutics, Inc. |
| 09/12/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 09/08/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
| 09/07/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
| 08/04/2022 |
8-K
| Quarterly results |
| 08/04/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/15/2022 |
8-K
| Quarterly results |
| 06/10/2022 |
8-K
| Quarterly results |
| 05/20/2022 |
8-K
| Quarterly results |
|